Publication & Citation Trends
Publications
0 total
Fully human monoclonal antibody targeting the cysteine-rich substrate-interacting region of ADAM17 on cancer cells
Cited by 3
Semantic Scholar
A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy OA
Cited by 10
Semantic Scholar
Integration of cancer-related genetic landscape of Eph receptors and ephrins with proteomics identifies a crosstalk between EPHB6 and EGFR. OA
Cited by 17
Semantic Scholar
Cell Surface Multimeric Assemblies Regulate Canonical and Noncanonical EphA2 Receptor Tyrosine Kinase Signaling OA
Cited by 2
Semantic Scholar
Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cells OA
Cited by 15
Semantic Scholar
From genetic data and structures to drug development: New approaches to target Eph receptors
Cited by 0
Semantic Scholar
Structure of the EphB6 receptor ectodomain OA
Cited by 8
Semantic Scholar
Ephrin-A1 and the sheddase ADAM12 are upregulated in COVID-19 OA
Cited by 15
Semantic Scholar
EphB6 receptor ectodomain
Cited by 0
Semantic Scholar
Research Topics
Axon Guidance and Neuronal Signaling
(12)
Angiogenesis and VEGF in Cancer
(7)
Chromatography in Natural Products
(6)
Bacterial Genetics and Biotechnology
(5)
Hemoglobinopathies and Related Disorders
(5)
Affiliations
Northeastern University
Memorial Sloan Kettering Cancer Center
University of Turku
Kettering University
Institute for Molecular Medicine Finland